Herbst Group LLC Raises Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Herbst Group LLC boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 19.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 4,830 shares of the exchange traded fund’s stock after buying an additional 800 shares during the quarter. Herbst Group LLC’s holdings in SPDR S&P Biotech ETF were worth $435,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Bank of New York Mellon Corp grew its stake in SPDR S&P Biotech ETF by 15.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,590 shares of the exchange traded fund’s stock worth $518,000 after purchasing an additional 744 shares in the last quarter. Envestnet Asset Management Inc. grew its stake in SPDR S&P Biotech ETF by 12.5% in the 2nd quarter. Envestnet Asset Management Inc. now owns 186,400 shares of the exchange traded fund’s stock valued at $17,281,000 after acquiring an additional 20,685 shares during the last quarter. Edgestream Partners L.P. lifted its holdings in SPDR S&P Biotech ETF by 184.4% in the 2nd quarter. Edgestream Partners L.P. now owns 10,068 shares of the exchange traded fund’s stock valued at $933,000 after purchasing an additional 6,528 shares in the last quarter. Mercer Global Advisors Inc. ADV increased its stake in shares of SPDR S&P Biotech ETF by 40.6% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 11,128 shares of the exchange traded fund’s stock valued at $1,032,000 after acquiring an additional 3,214 shares during the last quarter. Finally, Brighton Jones LLC acquired a new position in SPDR S&P Biotech ETF during the second quarter valued at approximately $208,000.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $87.97 on Friday. The firm’s fifty day moving average price is $94.09 and its 200 day moving average price is $96.94. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The company has a market capitalization of $6.71 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.